Department of Ophthalmology, Bayindir Hospital, Ankara, Turkey.
Kaskaloglu Hospital, Izmir, Turkey.
Int Ophthalmol. 2020 May;40(5):1069-1075. doi: 10.1007/s10792-020-01390-9. Epub 2020 Apr 23.
To evaluate the clinical outcomes following bilateral implantation of PanOptix intraocular lens (IOL).
This study included consecutive patients scheduled to undergo cataract or refractive lens exchange surgery between October 2017 and June 2018 at two centers. Manifest refraction, uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA, 60 cm) and uncorrected near visual acuity (UNVA, 40 cm), defocus curves, presence of dysphotopsia, need for spectacles, presence of posterior capsule opacification and visual function were evaluated at 6 months after surgery.
The IOL was implanted in 138 eyes of 69 patients. The mean binocular UDVA was 0.02 ± 0.05 logMAR, UIVA 0.06 ± 0.07 logMAR and UNVA 0.05 ± 0.07 logMAR. Defocus curve showed two peaks at 0.00 D and - 1.50 D. Complete spectacle independence was reported in 94.2% of the patients. The mean VF-14 test result was 97.7 ± 2.2 (93.2-100). Only one patient (1.4%) reported seeing bothersome halos. The presence of posterior capsule opacification was noted in seven eyes (10%), whereas Nd:Yag capsulotomy was required only in one eye.
This trifocal IOL provided excellent visual outcomes at all distances with high spectacle independence and patient's satisfaction.
评估 PanOptix 人工晶状体（IOL）双眼植入术后的临床效果。
本研究纳入了 2017 年 10 月至 2018 年 6 月在两个中心接受白内障或屈光性晶状体置换手术的连续患者。在术后 6 个月时评估了客观折射、未矫正远视力（UDVA）、未矫正中间视力（UIVA，60cm）和未矫正近视力（UNVA，40cm）、调节曲线、畏光情况、对眼镜的需求、后囊混浊和视觉功能。
该 IOL 共植入 69 例患者的 138 只眼。双眼平均 UDVA 为 0.02±0.05 logMAR，UIVA 为 0.06±0.07 logMAR，UNVA 为 0.05±0.07 logMAR。调节曲线在 0.00D 和-1.50D 处有两个峰值。94.2%的患者完全不需要戴眼镜。VF-14 测试的平均结果为 97.7±2.2（93.2-100）。只有 1 名患者（1.4%）报告看到恼人的光环。7 只眼（10%）出现后囊混浊，仅 1 只眼需要行 Nd:Yag 后囊切开术。
这款三焦点 IOL 在所有距离均提供了出色的视觉效果，具有较高的脱镜率和患者满意度。
